The heart in liver transplantation

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 67, Issue 3, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Anticoagulation in chronic liver disease
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
Volume 68, Issue 5, Pages (May 2018)
Volume 61, Issue 6, Pages (December 2014)
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: A contemporary view and look forward  Michael J. Krowka, Russell.
Non-invasive diagnosis of non-alcoholic fatty liver disease
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 58, Issue 3, Pages (March 2013)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Vicente Arroyo, Carlos Terra, Pere Ginès  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Volume 69, Issue 5, Pages (November 2018)
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Who should get a liver graft?
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The changing role of beta-blocker therapy in patients with cirrhosis
Reply to: “It takes two “eyes” to see in depth”
Volume 57, Issue 5, Pages (November 2012)
Juan-Carlos García-Pagán, Jorge Gracia-Sancho, Jaume Bosch 
Volume 53, Issue 6, Pages (December 2010)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Portal vein thrombosis, cirrhosis, and liver transplantation
Immunosuppression in liver transplant recipients with renal impairment
Immigration and viral hepatitis
Non-invasive evaluation of liver fibrosis using transient elastography
Evolution of liver transplantation for hepatocellular carcinoma
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
The use of hemospray in portal hypertensive bleeding; a case series
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Volume 60, Issue 6, Pages (June 2014)
Manuel Hernández-Guerra, Anna Hadjihambi, Rajiv Jalan 
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
Volume 54, Issue 6, Pages (June 2011)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

The heart in liver transplantation Cristina Ripoll, Raquel Yotti, Javier Bermejo, Rafael Bañares  Journal of Hepatology  Volume 54, Issue 4, Pages 810-822 (April 2011) DOI: 10.1016/j.jhep.2010.11.003 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Diagram of pathophysiology of portal hypertension. The increase in portal pressure is defined by Ohm’s law, that states that pressure depends on resistance and flow. In cirrhosis there is an initial increase in intrahepatic resistance. This increase in intrahepatic resistance leads to splanchnic vasodilation which in turn leads to central hypovolemia and activation of vasoactive mechanisms that increase cardiac output and kidney sodium retention. This leads to an increase in portal venous flow. The combination of both mechanisms leads to an increase in portal pressure. Furthermore, increased intrahepatic resistance also leads to an independent increase in kidney sodium retention and further increases portal venous flow. Journal of Hepatology 2011 54, 810-822DOI: (10.1016/j.jhep.2010.11.003) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Algorithm for pretransplant cardiac evaluation, taking into account the most frequently identified problem in LT candidates. Most centers perform EKG and echocardiography on a routine basis. Screening of patients with risk factors for CAD is also recommended. According to the findings in these initial examinations, further tests will be performed. Journal of Hepatology 2011 54, 810-822DOI: (10.1016/j.jhep.2010.11.003) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 810-822DOI: (10. 1016/j. jhep. 2010. 11 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions